Table 2.
Antimicrobial agent | Test |
MIC range (min to max) [µg/mL] |
MIC50 [µg/mL] |
MIC90 [µg/mL] |
Breakpoint resistance [µg/mL] |
% resistance (no. of strains) |
---|---|---|---|---|---|---|
Nadifloxacin | Agar dilution | 0.097 to 0.390 | 0.195 | 0.195 | ≥4† | 0.00 (0) |
Clindamycin | E‐Test | 0.023 to >256 | 0.047 | 0.750 | ≥8†, ‡, §, ¶ | 4.11 (3) |
Erythromycin | Agar dilution | <0.024 to >200 | 0.024 | 200 |
≥2‡ ≥8† |
For both breakpoints: 15.07 (11) |
Tetracycline | Agar dilution | 0.390 to 3.125 | 0.390 | 0.780 | ≥16‡, § | 0.00 (0) |
Alba et al. 1 .
Sardana et al. 8 .
Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing, 29th Edition, CLSI Supplement M100, Wayne PA: Pennsylvania; 2019.
The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0, 2019. http://www.eucast.org.